Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Putnak

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Virus Research|June 23, 2009
Phenotypic analysis of dengue virus isolates associated with dengue fever and dengue hemorrhagic fever for cellular attachment, replication and interferon signaling abilityRatree Takhampunya, Dupeh R Palmer, Sasha McClain, et al.
The American Journal of Tropical Medicine and Hygiene|December 5, 2012
A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adultsStephen J Thomas, Kenneth H Eckels, Isabelle Carletti, et al.
Msphere|January 24, 2020
Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1Heather Friberg, Luis J Martinez, Leyi Lin, et al.
The Journal of Infectious Diseases|December 11, 2012
Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccinesWellington Sun, Kenneth H Eckels, J Robert Putnak, et al.
The American Journal of Tropical Medicine and Hygiene|July 9, 2008
Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodiesJ Robert Putnak, Rafael de la Barrera, Timothy Burgess, et al.
Clinical and Vaccine Immunology : CVI|March 13, 2015
Immunogenicity and efficacy of flagellin-envelope fusion dengue vaccines in mice and monkeysGe Liu, Langzhou Song, David W C Beasley, et al.
The American Journal of Tropical Medicine and Hygiene|March 14, 2008
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive childrenSriluck Simasathien, Stephen J Thomas, Veerachai Watanaveeradej, et al.
Vaccine|January 26, 2010
Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeysDavid E Clements, Beth-Ann G Coller, Michael M Lieberman, et al.
The American Journal of Tropical Medicine and Hygiene|February 4, 2015
An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaquesStefan Fernandez, Stephen J Thomas, Rafael De La Barrera, et al.
The American Journal of Tropical Medicine and Hygiene|August 5, 2011
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infantsVeerachai Watanaveeradej, Sriluck Simasathien, Ananda Nisalak, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Virus Research|June 23, 2009
Phenotypic analysis of dengue virus isolates associated with dengue fever and dengue hemorrhagic fever for cellular attachment, replication and interferon signaling abilityRatree Takhampunya, Dupeh R Palmer, Sasha McClain, et al.
The American Journal of Tropical Medicine and Hygiene|December 5, 2012
A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adultsStephen J Thomas, Kenneth H Eckels, Isabelle Carletti, et al.
Msphere|January 24, 2020
Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1Heather Friberg, Luis J Martinez, Leyi Lin, et al.
The Journal of Infectious Diseases|December 11, 2012
Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccinesWellington Sun, Kenneth H Eckels, J Robert Putnak, et al.
The American Journal of Tropical Medicine and Hygiene|July 9, 2008
Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodiesJ Robert Putnak, Rafael de la Barrera, Timothy Burgess, et al.
Clinical and Vaccine Immunology : CVI|March 13, 2015
Immunogenicity and efficacy of flagellin-envelope fusion dengue vaccines in mice and monkeysGe Liu, Langzhou Song, David W C Beasley, et al.
The American Journal of Tropical Medicine and Hygiene|March 14, 2008
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive childrenSriluck Simasathien, Stephen J Thomas, Veerachai Watanaveeradej, et al.
Vaccine|January 26, 2010
Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeysDavid E Clements, Beth-Ann G Coller, Michael M Lieberman, et al.
The American Journal of Tropical Medicine and Hygiene|February 4, 2015
An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaquesStefan Fernandez, Stephen J Thomas, Rafael De La Barrera, et al.
The American Journal of Tropical Medicine and Hygiene|August 5, 2011
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infantsVeerachai Watanaveeradej, Sriluck Simasathien, Ananda Nisalak, et al.
Pageof 4